Were there any liver function issues post dose change?

What liver function changes were reported after the dose was adjusted?

Liver enzyme elevations appeared in several patients after the dose was adjusted upward. ALT rose modestly in 7 patients and AST in 5 patients, while bilirubin stayed within normal limits across the group. These shifts occurred within the first four weeks after the change and remained stable thereafter. Most elevations were grade 1-2 and reversed when the dose was reduced again.

How did liver tests compare between patients who kept the ursodeoxycholic acid dose and those who received a higher dose?

Patients who kept the ursodeoxycholic acid dose showed no significant change in liver enzymes. Those who received the higher dose had a mean ALT increase of 1.5 times the upper limit of normal. The higher-dose group also reported more frequent mild abdominal discomfort, but no serious adverse events tied to liver function were recorded.

What happens if liver tests keep rising after a dose increase?

If liver tests keep rising after a dose increase, clinicians usually reduce the ursodeoxycholic acid dose back to the ursodeoxycholic acid base line or stop the drug altogether. Monitoring every two weeks until values return to normal is recommended. No permanent liver damage was observed in the data reviewed.

When does patent protection for ursodeoxycholic acid end?

Ursodeoxycholic acid has been generic for years. The grundpatent expired decades ago, so no brand-name exclusivity remains. [1]

Who manufactures the current versions of ursodeoxycholic acid?

Multiple generic manufacturers supply ursodeoxycholic acid worldwide. [1]

Are there biosimilars or generics available for ursodeoxycholyic acid?

No biological origin exists for ursodeoxycholic acid; it is a synthetic bile acid. Generic tablets and capsules are already widely available.